RETRACTED: γ-cleavage-independent functions of presenilin, nicastrin, and aph-1 regulate cell-junction organization and prevent tau toxicity in vivo (Retracted article. See vol. 53, pg. 463, 2007)

被引:21
作者
Doglio, Laura E.
Kanwar, Ritu
Jackson, George R.
Perez, Mar
Avila, Jesus
Dingwal, Colin
Dotti, Carlos G.
Fortini, Mark E. [1 ]
Feiguin, Fabian
机构
[1] NCI, Canc Res Ctr, Frederick, MD 21702 USA
[2] Univ Turin, Cavalieri Ottolenghi Sci Inst, I-10043 Turin, Italy
[3] Flanders Interuniv Inst Biotechnol VIB, B-3000 Louvain, Belgium
[4] Catholic Univ Louvain, Dept Human Genet, B-3000 Louvain, Belgium
[5] Univ Calif Los Angeles, Dept Neurol, Neurogenet Program, David Geffen Sch Med, Los Angeles, CA 90095 USA
[6] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, Madrid 28049, Spain
[7] GlaxoSmithKline, Neurol & GI CEDD, Harlow CM19 5AW, Essex, England
关键词
D O I
10.1016/j.neuron.2006.03.038
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Genetic analysis of familial Alzheimer's disease has revealed that mutations in the gamma-secretase enzyme presenilin promote toxic A beta secretion; however, presenilin mutations might also influence tau hyperphosphorylation and neurodegeneration through gamma-secretase-independent mechanisms. To address this possibility and determine whether other components of the gamma-secretase complex possess similar regulatory functions, we analyzed the roles of presenilin, nicastrin, and aph-1 in a Drosophila model for tau-induced neurodegeneration. Here, we show that presenilin and nicastrin prevent tau toxicity by modulating the PI3K/Akt/GSK3 beta phosphorylation pathway, whereas aph-1 regulates aPKC/PAR-1 activities. Moreover, we found that these transmembrane proteins differentially regulate the intracellular localization of GSK3 beta and aPKC at cell junctions. Inhibition of gamma-secretase activity neither interfered with these kinase pathways nor induced aberrant tau phosphorylation. These results establish new in vivo molecular functions for the three components of the gamma-secretase complex and reveal a different mechanism that might contribute to neuronal degeneration in Alzheimer's disease.
引用
收藏
页码:359 / 375
页数:17
相关论文
共 53 条
[1]   PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations [J].
Baki, L ;
Shioi, J ;
Wen, P ;
Shao, ZP ;
Schwarzman, A ;
Gama-Sosa, M ;
Neve, R ;
Robakis, NK .
EMBO JOURNAL, 2004, 23 (13) :2586-2596
[2]  
Baumeister R, 1997, Genes Funct, V1, P149
[3]   Drosophila as a model for human neurodegenerative disease [J].
Bilen, J ;
Bonini, NM .
ANNUAL REVIEW OF GENETICS, 2005, 39 :153-171
[4]   Nicastrin is required for Presenilin-mediated transmembrane cleavage in Drosophila [J].
Chung, HM ;
Struhl, G .
NATURE CELL BIOLOGY, 2001, 3 (12) :1129-1132
[5]   An Alzheimer's disease-linked PS1 variant rescues the developmental abnormalities of PS1-deficient embryos [J].
Davis, JA ;
Naruse, S ;
Chen, H ;
Eckman, C ;
Younkin, S ;
Price, DL ;
Borchelt, DR ;
Sisodia, SS ;
Wong, PC .
NEURON, 1998, 20 (03) :603-609
[6]   Aph-1, Pen-2, and nicastrin with presenilin generate an active γ-secretase complex [J].
De Strooper, B .
NEURON, 2003, 38 (01) :9-12
[7]   A novel presenilin 1 mutation associated with Pick's disease but not β-amyloid plaques [J].
Dermaut, B ;
Kumar-Singh, S ;
Engelborghs, S ;
Theuns, J ;
Rademakers, R ;
Sacrens, J ;
Pickut, BA ;
Peeters, K ;
van den Broeck, M ;
Vennekens, K ;
Claes, S ;
Cruts, M ;
Cras, P ;
Martin, JJ ;
Van Broeckhoven, C ;
De Deyn, PP .
ANNALS OF NEUROLOGY, 2004, 55 (05) :617-626
[8]   Forebrain degeneration and ventricle enlargement caused by double knockout of Alzheimer's presenilin-1 and presenilin-2 [J].
Feng, RB ;
Wang, HM ;
Wang, JL ;
Shrom, D ;
Zeng, XM ;
Tsien, JZ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (21) :8162-8167
[9]   Formation of neurofibrillary tangles in P301L tau transgenic mice induced by Aβ42 fibrils [J].
Götz, J ;
Chen, F ;
van Dorpe, J ;
Nitsch, RM .
SCIENCE, 2001, 293 (5534) :1491-1495
[10]   Medicine - The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics [J].
Hardy, J ;
Selkoe, DJ .
SCIENCE, 2002, 297 (5580) :353-356